MedTrace Logo

Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations

NCT01316783 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2026-05-22

No results posted yet for this study

Summary

Background:

\- African Americans have one of the highest rates of type 2 diabetes in the United States, and often have other medical problems related to obesity and cardiovascular disease. These conditions have various risk factors, including high blood sugar levels, high cholesterol levels, and insulin resistance. However, these risk factors have not been studied very closely in individuals with African ancestry, including Afro-Caribbean and sub-Saharan Africa migrant populations. Researchers are interested in conducting a genetic study on obesity, adult-onset diabetes, heart disease, and other common health conditions in individuals with African ancestry.

Objectives:

\- To collect genetic and non-genetic information from individuals with African ancestry to study common health conditions related to obesity, adult-onset diabetes, and heart disease.

Eligibility:

\- Individuals at least 18 years of age who self-identify as African American, Afro-Caribbean, or migrants from sub Saharan Africa.

Design:

* Participants will undergo a physical examination and will provide a blood sample for study.
* Participants will also answer questions about personal and family medical history and current lifestyle behaviors.
* No treatment will be provided as part of this protocol.

Conditions

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    lead NIH

Principal Investigators

  • Charles N Rotimi, M.D. · National Human Genome Research Institute (NHGRI)

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01316783 on ClinicalTrials.gov